Global In-Vitro Fertilization Market Strategic Research Report

Global demand for in-vitro fertilization services and supporting technologies has transitioned from a niche clinical segment into a structurally resilient, high-growth healthcare market. An estimated 1-in-6 couples worldwide now experience infertility, while delayed family formation, rising maternal age at first birth, and declining sperm quality across OECD populations continue to expand the addressable patient pool at a rate that outpaces clinical capacity in most geographies.

In 2025, three forces are simultaneously reshaping the market's architecture: the rapid adoption of preimplantation genetic testing (PGT), which improves live birth rates and commands a meaningful price premium over conventional cycles; the industrialization of frozen embryo transfer (FET) protocols, which decouples embryo banking from fresh transfer cycles and multiplies per-patient revenue streams; and the accelerating entry of AI-driven embryo selection platforms, which are compressing the competence gap between tier-1 fertility centers and mid-market clinic networks.

The global IVF market reached an estimated USD 22.01 billion in 2024, advancing from USD 18.42 billion in 2022, representing a historical CAGR of approximately 9.4% over 2022-2024 (Navadhi Market Research Estimate). The base-year estimate for 2025 stands at USD 24.08 billion. The market is projected to reach USD 41.82 billion by 2031, compounding at a 9.6% CAGR over the 2025-2031 forecast period. Volume throughput is expected to grow from 3.51 million cycles in 2025 to 5.60 million cycles by 2031, driven by clinic network expansion in Asia-Pacific and Latin America, rising PGT penetration in North America, and the continued scaling of frozen embryo transfer protocols globally.

Employer-sponsored fertility benefits in the United States now cover IVF at approximately 42% of large employers, up from under 25% five years ago, materially lowering the out-of-pocket barrier for the highest-value demographic. In Europe, public reimbursement programs in Denmark, Belgium, and Israel continue to sustain cycle volumes at above-replacement levels, while rapid middle-class expansion and surging fertility tourism in Southeast Asia, the Gulf Cooperation Council, and India are extending the market's geographic frontier well beyond its historical base.